Takeda Pharmaceutical Co Ltd
XMUN:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
|
I
|
Ipsos SA
XMUN:IPZ
|
FR |
|
Dev Clever Holdings PLC
LSE:DEV
|
UK |
|
I
|
Intertek Group PLC
F:IT1
|
UK |
|
A
|
Adtalem Global Education Inc
F:DVY
|
US |
|
Tokyo Metro Co Ltd
F:XO7
|
JP |
|
Bank of America Corp
NYSE:BAC
|
US |
|
LendLease Group
F:LLC
|
AU |
|
Texas Pacific Land Corp
NYSE:TPL
|
US |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 34.07 EUR with a low forecast of 28.17 EUR and a high forecast of 43.93 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
34.07
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 34.07 EUR with a low forecast of 28.17 EUR and a high forecast of 43.93 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
